Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times UK
International Business Times UK
Niloy Chakrabarti

Ark Invest CEO Cathie Wood Boosts Stake in Firms Making Breakthroughs in Gene Editing, AI Drug Development, and Obesity Drugs

The Ark Genomic Revolution ETF is now worth $1.34 billion. (Credit: LinkedIn)

Ark Invest CEO Cathie Wood shot to fame when all the exchange-traded funds (ETFs) managed by her investment management firm jumped by over 100% each in 2020 compared to the S&P 500's mere 16% returns.

Wood is known for her singular investing approach and bets on disruptive, high-growth firms, including generative AI, genome development, autonomous robotics, space exploration, cryptocurrency, and 3D printing. With the philosophy that today's disruptive innovation will shape tomorrow's future and is the shortest path to growth, Wood often takes bold calls and treads investing paths Wall Street majors usually avoid.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.